GLP-1 for Weight Loss: How Much, How Fast, How Long

GLP-1 medications produce the largest weight loss of any FDA-approved drug class — 15% on semaglutide and 22% on tirzepatide in published trials. Here is what actually happens during treatment: timeline, maintenance, weight regain after stopping, and how to maximize results.

Last updated May 1, 2026.

Advertising disclosure: GLP Insights is reader-supported. When you book a consultation or purchase through our partner links, we may earn a commission at no additional cost to you. This does not influence which providers or medications we discuss. Learn how this site is funded.

Start Weight Loss Consultation

Licensed providers · All 50 states · No insurance required

✓ Updated monthly with FDA + clinical research ✓ Affiliate-supported, editorially independent ✓ Plain-English explanations of complex medical topics

The Key Numbers

Medication	Mean weight loss	Trial	Duration
Semaglutide 2.4 mg (Wegovy)	~14.9%	STEP-1	68 weeks
Tirzepatide 15 mg (Zepbound)	~20.9% (some readouts ~22%)	SURMOUNT-1	72 weeks
Tirzepatide 10 mg	~19.5%	SURMOUNT-1	72 weeks
Tirzepatide 5 mg	~15.0%	SURMOUNT-1	72 weeks
Liraglutide 3 mg (Saxenda)	~8.0%	SCALE	56 weeks
Phentermine + topiramate	~9.3%	CONQUER	56 weeks
Naltrexone + bupropion	~6.1%	COR-I	56 weeks

Realistic Timeline

Weeks 1–4: Starting dose

Most patients notice reduced appetite within 1–2 weeks. Weight loss is small (1–2 kg) but often rapid as eating drops. Mild nausea is common.

Weeks 5–12: Titration

Dose escalates every 4 weeks. Weight loss accelerates. Many patients lose 5–8% of starting weight by week 12. Side effects peak when escalating.

Weeks 13–24: Mid-treatment

Approaching maintenance dose. Weight loss continues but at a slower per-week pace. Habits and food preferences often shift.

Weeks 25–52: Maintenance

Most weight loss occurs by month 12. Some patients continue to lose slowly; others plateau. Long-term trial data show sustained results when therapy continues.

Beyond Year 1

STEP-5 showed weight loss continuing or stabilizing through 104 weeks. Discontinuation is followed by significant regain (STEP-4).

How to Maximize Weight Loss on GLP-1

Protein-adequate diet. Aim for 1.2–1.6 g protein per kg body weight to preserve lean mass during weight loss.
Resistance training. 2–3 sessions per week to maintain muscle.
Hydration. Reduced food intake also means less water from food; aim for adequate fluid intake daily.
Slow eating. With slowed gastric emptying, eating fast causes nausea. Smaller, slower meals are better tolerated.
Consistency. Skipping doses reduces consistency of appetite suppression.
Sleep and stress management. Both affect appetite hormones independently of GLP-1.

Start GLP-1 Weight Loss Plan

Licensed providers · All 50 states · No insurance required

What About Weight Regain After Stopping?

The STEP-4 trial randomized patients who had lost weight on semaglutide to continue or switch to placebo. The placebo group regained about two-thirds of the lost weight within a year. The continued-semaglutide group maintained their losses.

This is consistent with the broader picture of obesity as a chronic, relapsing condition. Most evidence supports long-term GLP-1 therapy for those who tolerate it, similar to long-term statins for high cholesterol.

Microdosing and Maintenance Strategies

Some clinicians prescribe lower maintenance doses ("microdosing") after target weight is reached, both to reduce cost and to maintain appetite control without ongoing weight loss. See microdose page for the practice in detail.

Body Composition: What Are You Losing?

Like any rapid weight loss, GLP-1-induced weight loss is a mix of fat and lean tissue. Estimates from imaging studies suggest 20–40% of weight loss can be lean tissue (which includes water, organ mass, and muscle). Resistance training and adequate protein significantly reduce lean mass loss.

Non-Weight Benefits

Improved HbA1c (diabetes or pre-diabetes)
Lower blood pressure
Improved lipid profile
Reduced cardiovascular event risk (Wegovy: SELECT trial)
Improved obstructive sleep apnea (Zepbound: SURMOUNT-OSA)
Reduced inflammation markers
Improved quality of life and physical function

What If GLP-1 Doesn't Work for Me?

About 10–15% of patients in trials are "non-responders" — they lose less than 5% body weight at the maximum dose. Options:

Switch to tirzepatide if currently on semaglutide
Reassess for confounders: sleep, alcohol, untreated thyroid, depression
Combine with structured behavioral or nutrition support
Discuss surgical options (bariatric surgery still produces the largest sustained weight loss)

Frequently Asked Questions

How much weight do you lose on GLP-1? +

Semaglutide produced about 15% average body weight loss in STEP-1 over 68 weeks; tirzepatide produced about 22% in SURMOUNT-1 at 72 weeks. Individual results vary substantially.

How quickly does GLP-1 weight loss start? +

Many patients notice reduced appetite within the first 1–2 weeks, with measurable weight loss within 4–8 weeks. Maximum benefit typically takes 6–12 months as dosing escalates.

Do I gain weight back if I stop GLP-1? +

Clinical data show significant weight regain after stopping. The STEP-4 trial reported regain of about two-thirds of lost weight within a year of discontinuation.

Can I lose weight on GLP-1 without diet changes? +

Most patients lose weight even without intentional diet changes because appetite is reduced. However, paired with protein-adequate diet and resistance training, outcomes are better and lean mass is preserved.

Sources

STEP-1, STEP-4, STEP-5 trials. NEJM 2021–2023.
SURMOUNT-1 trial. NEJM 2022.
SELECT trial (CV outcomes on Wegovy). NEJM 2023.